Septer­na files for Nas­daq list­ing as biotech IPOs come to life

Septer­na is join­ing biotech’s IPO on-deck cir­cle, prepar­ing for a pub­lic of­fer­ing with two oth­er star­tups that have sim­i­lar am­bi­tions.

It an­nounced its plans in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER